Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection

BACKGROUND: Little is known about how new generation adenosine triphosphate (ATP)-competitive mechanistic target of rapamycin (mTOR) kinase inhibitors (TORKinibs) affect immunity and allograft rejection. METHODS: mTOR complex (C) 1 and 2 signaling in dendritic cells (DC) and T cells was analyzed by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Fantus, Daniel, Dai, Helong, Ono, Yoshihiro, Watson, Alicia, Yokota, Shinichiro, Mohib, Kanishka, Yoshida, Osamu, Ross, Mark A., Watkins, Simon C., Ramaswami, Bala, Valusjkikh, Anna, Rothstein, David M., Thomson, Angus W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709200/
https://ncbi.nlm.nih.gov/pubmed/28885497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados